Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.

MLA

De Luca G, et al. “Relationship between Patient’s Risk Profile and Benefits in Mortality from Adjunctive Abciximab to Mechanical Revascularization for ST-Segment Elevation Myocardial Infarction: A Meta-Regression Analysis of Randomized Trials.” Journal of the American College of Cardiology (JACC), vol. 47, no. 3, Feb. 2006, pp. 685–86. EBSCOhost, https://doi.org/10.1016/j.jacc.2005.11.018.

APA

De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Bonizzoni E, Topol EJ, & Chiariello M. (2006). Relationship between patient’s risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. Journal of the American College of Cardiology (JACC), 47(3), 685–686. https://doi.org/10.1016/j.jacc.2005.11.018

Chicago

De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Bonizzoni E, Topol EJ, and Chiariello M. 2006. “Relationship between Patient’s Risk Profile and Benefits in Mortality from Adjunctive Abciximab to Mechanical Revascularization for ST-Segment Elevation Myocardial Infarction: A Meta-Regression Analysis of Randomized Trials.” Journal of the American College of Cardiology (JACC) 47 (3): 685–86. doi:10.1016/j.jacc.2005.11.018.